SciCombinator

Discover the most talked about and latest scientific content & concepts.

The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

OPEN Journal of the American College of Cardiology | 18 Feb 2017

MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, JL Halperin, CS Ma, K Zint, A Elsaesser, DB Bartels and GY Lip
Abstract
GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non-vitamin K antagonist oral anticoagulant (NOAC), became available.
Tweets*
55
Facebook likes*
3
Reddit*
0
News coverage*
35
Blogs*
1
SC clicks
0
Concepts
Heart, Atrial flutter, Stroke, Dabigatran, Anticoagulant, Warfarin, Atrial fibrillation
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com